Performance
Stock factor profile
SIGACHI
SIGACHI · Healthcare · Pharmaceuticals & Biotechnology
Sigachi Industries Ltd. engages in the manufacture and sale of microcrystalline cellulose. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-11-15. The firm is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Company’s products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The firm's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. The company produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The firm offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. The company operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The firm serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.
Equity review factors
Factor profile
Factor scores are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags and screen results for SIGACHI are part of the Wright portfolio review.
Run your free portfolio reviewFundamental snapshot
Fundamentals at a glance
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.